Works matching AU Xu, Jianming


Results: 382
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13

    Distinct biophysical and chemical mechanisms governing sucrose mineralization and soil organic carbon priming in biochar amended soils: evidence from 10 years of field studies.

    Published in:
    Biochar, 2024, v. 6, n. 1, p. 1, doi. 10.1007/s42773-024-00327-0
    By:
    • Zhang, Haoli;
    • Ma, Tao;
    • Wang, Lili;
    • Yu, Xiuling;
    • Zhao, Xiaorong;
    • Gao, Weida;
    • Van Zwieten, Lukas;
    • Singh, Bhupinder Pal;
    • Li, Guitong;
    • Lin, Qimei;
    • Chadwick, David R.;
    • Lu, Shenggao;
    • Xu, Jianming;
    • Luo, Yu;
    • Jones, David L.;
    • Jeewani, Peduruhewa H.
    Publication type:
    Article
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31

    Furazolidone‐containing triple and quadruple eradication therapy for initial treatment for Helicobacter pylori infection: A multicenter randomized controlled trial in China.

    Published in:
    Helicobacter, 2018, v. 23, n. 5, p. 1, doi. 10.1111/hel.12496
    By:
    • Xie, Yong;
    • Zhang, Zhenyu;
    • Hong, Junbo;
    • Liu, Wenzhong;
    • Lu, Hong;
    • Du, Yiqi;
    • Wang, Weihong;
    • Xu, Jianming;
    • Wang, Xuehong;
    • Huo, Lijuan;
    • Zhang, Guiying;
    • Lan, Chunhui;
    • Li, Xiaoyan;
    • Li, Yanqing;
    • Wang, Hong;
    • Zhang, Guoxin;
    • Zhu, Yin;
    • Shu, Xu;
    • Chen, Ye;
    • Wang, Jiangbin
    Publication type:
    Article
    32
    33
    34
    35
    36

    Subgroup Analysis by Liver Metastasis in the FRESCO Trial Comparing Fruquintinib versus Placebo Plus Best Supportive Care in Chinese Patients with Metastatic Colorectal Cancer.

    Published in:
    OncoTargets & Therapy, 2021, v. 14, p. 4439, doi. 10.2147/OTT.S307273
    By:
    • Qin, Shukui;
    • Xu, Rui-Hua;
    • Shen, Lin;
    • Xu, Jianming;
    • Bai, Yuxian;
    • Yang, Lei;
    • Deng, Yanhong;
    • Chen, Zhen-dong;
    • Zhong, Haijun;
    • Pan, Hongming;
    • Guo, Weijian;
    • Shu, Yongqian;
    • Yuan, Ying;
    • Zhou, Jianfeng;
    • Xu, Nong;
    • Liu, Tianshu;
    • Ma, Dong;
    • Wu, Changping;
    • Cheng, Ying;
    • Chen, Donghui
    Publication type:
    Article
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46

    Randomized multicenter phase III study of a modified docetaxel and cisplatin plus fluorouracil regimen compared with cisplatin and fluorouracil as first-line therapy for advanced or locally recurrent gastric cancer.

    Published in:
    Gastric Cancer, 2016, v. 19, n. 1, p. 234, doi. 10.1007/s10120-015-0457-4
    By:
    • Wang, Jinwan;
    • Xu, Ruihua;
    • Li, Jian;
    • Bai, Yuxian;
    • Liu, Tianshu;
    • Jiao, Shunchang;
    • Dai, Guanghai;
    • Xu, Jianming;
    • Liu, Yunpeng;
    • Fan, Nanfeng;
    • Shu, Yongqian;
    • Ba, Yi;
    • Ma, Dong;
    • Qin, Shukui;
    • Zheng, Leizhen;
    • Chen, Weichang;
    • Shen, Lin
    Publication type:
    Article
    47

    Bevacizumab plus capecitabine and cisplatin in Chinese patients with inoperable locally advanced or metastatic gastric or gastroesophageal junction cancer: randomized, double-blind, phase III study (AVATAR study).

    Published in:
    Gastric Cancer, 2015, v. 18, n. 1, p. 168, doi. 10.1007/s10120-014-0351-5
    By:
    • Shen, Lin;
    • Li, Jin;
    • Xu, Jianming;
    • Pan, Hongming;
    • Dai, Guanghai;
    • Qin, Shukui;
    • Wang, Liwei;
    • Wang, Jinwan;
    • Yang, Zhenzhou;
    • Shu, Yongqian;
    • Xu, Ruihua;
    • Chen, Lei;
    • Liu, Yunpeng;
    • Yu, Shiying;
    • Bu, Lilian;
    • Piao, Yongzhe
    Publication type:
    Article
    48

    Efficacy and safety of surufatinib plus toripalimab, a chemotherapy-free regimen, in patients with advanced gastric/gastroesophageal junction adenocarcinoma, esophageal squamous cell carcinoma, or biliary tract cancer.

    Published in:
    Cancer Immunology, Immunotherapy, 2024, v. 73, n. 7, p. 1, doi. 10.1007/s00262-024-03677-7
    By:
    • Zhang, Panpan;
    • Chen, Zhendong;
    • Shi, Si;
    • Li, Zhiping;
    • Ye, Feng;
    • Song, Lijie;
    • Zhang, Yanqiao;
    • Yin, Fei;
    • Zhang, Xing;
    • Xu, Jianming;
    • Cheng, Ying;
    • Su, Weiguo;
    • Shi, Michael;
    • Fan, Songhua;
    • Tan, Panfeng;
    • Zhong, Chen;
    • Lu, Ming;
    • Shen, Lin
    Publication type:
    Article
    49
    50

    New single capsule of bismuth, metronidazole and tetracycline given with omeprazole versus quadruple therapy consisting of bismuth, omeprazole, amoxicillin and clarithromycin for eradication of Helicobacter pylori in duodenal ulcer patients: a Chinese prospective, randomized, multicentre trial.

    Published in:
    2018
    By:
    • Xie, Yong;
    • Pan, Xiaolin;
    • Li, Yan;
    • Wang, Huahong;
    • Du, Yiqi;
    • Xu, Jianming;
    • Wang, Jiangbin;
    • Zeng, Zhirong;
    • Chen, Ye;
    • Zhang, Guoxin;
    • Wu, Kaichun;
    • Liu, Dongsheng;
    • Lv, Nonghua
    Publication type:
    journal article